Here are Tuesday's biggest analyst calls of the day: Nvidia, AMD, Procter & Gamble, Meta & more

Wall Street analysts issued a broad slate of upgrades and positive initiations, including AMD price-target increases to $705 at Mizuho and $800 at Citi, while Wells Fargo raised Meta’s target to $1,000 from $796. Calls were not uniformly positive: Goldman cut Netflix’s target to $90 from $94 but reiterated Buy, and Berenberg downgraded Nike to Sell, citing a guided high-single-digit-percentage FY27 sales decline. The roundup is primarily stock-specific analyst commentary, with no reported market reaction.

Analysis

This is a noisy broker-call tape, not a broad earnings signal: target changes and rating actions can move positioning over days, but only estimate revisions and reported results can sustain a move over the next 1–3 months. The more consequential mechanism is the potential divergence in AI infrastructure winners. AMD’s case depends on server-CPU demand translating into durable share and profitable shipments; customer concentration and competitive responses matter as much as headline AI capex. GPU demand supporting NVDA does not automatically validate every AI-linked estimate, while rising operating costs could leave META with near-term EPS pressure even if its product cycle is strategically promising. Verify actual customer revenue exposure and company guidance before treating broker estimates as evidence.

The clearest negative earnings-revision risk is NKE: weaker differentiated-category demand can force promotions, pressure gross margin, and give share to competitors, so the downside is not limited to slower revenue. Conversely, PG’s operating leverage is conditional: oil, logistics, and pricing/mix must not overwhelm volume. These are multi-quarter tests, not same-day conclusions. Calls on small or specialized names such as PSQL and STDN have especially high execution, liquidity, and valuation risk; analyst enthusiasm is not independent validation. Overall, mildly positive call flow looks more useful for identifying watch items than buying a basket indiscriminately.

Key Decisions for Investors

• Prefer a staged, catalyst-led long in AMD over chasing the target-price revisions: add only if upcoming results/guidance confirm server-CPU growth and improving share without material margin deterioration. The thesis is falsified by weak data-center CPU trends, customer concentration becoming visible in results, or guidance failing to convert demand into earnings. Avoid treating NVDA strength as proof of AMD-specific execution.
• Consider a small relative-value position long PG / short NKE, entered on strength in NKE rather than after a sharp gap down. The thesis is continued divergence in earnings quality and consumer demand over the next 1–3 quarters, not a direct industry hedge. Reduce or exit if NKE stabilizes sales and promotions while PG misses underlying sales or shows input-cost pressure overwhelming operating leverage; check valuation and factor exposure before sizing.
• Keep SWKS/QRVO on alert, not as an automatic deal-arbitrage trade: verify the transaction status, legal close, consideration, and integration terms independently before positioning. If confirmed, monitor realized cost savings and customer retention over coming quarters; any delay, regulatory issue, or lost business would undermine the synergy case.
• Do not trade the analyst-call list as a basket. For thinly traded or early-stage quantum names, require liquidity, cash runway, and independently verifiable order/revenue evidence before taking exposure; absent those checks, the risk/reward is not established.